Skip to main content
. 2026 Jan 30;15:e75670. doi: 10.2196/75670

Table 2.

Secondary outcomes and the instruments we will use.

Outcome and measures Instruments
Main secondary outcomes

Cognitive score
  • Montreal Cognitive Assessment (face-to-face and telephone versions) [31,32]


Pain VASa
  • 100-mm VAS (numerical; 100 being the worst possible pain) [33]


Sleep self-assessment
  • Global Sleep Assessment Questionnaire (11 items with response options of “never,” “sometimes,” “usually,” and “always”; item responses were converted to a common scale from 0 to 100, with a higher score indicating greater likelihood of presence of the disorder) [34]

Additional secondary outcomes

Sleep effectiveness
  • Actigraphy registration 2 weeks before and after the intervention (subgroup only)


Quality of life
  • EQ-5D-5L (Norwegian population norm valuation); measured on a scale from 0 to 1, with 1 representing perfect health [35]


Dependence-like behavior
  • Severity of Dependence Scale (5 questions, total score range from 0 to 15, with 15 being the most severe) [36]


Additional cognitive assessments
  • Cognistat (numerical score from 0 to 84, with 84 being the best) [37]

  • CFIb (Norwegian self-assessed cognitive instrument) and FASc word score


Polypharmacy
  • Number of drugs used regularly


Anxiety and depression
  • Hospital Anxiety and Depression Scale (0-42, with 42 being the worst) [31,38]


Willingness to change
  • Qualitative group interview


Acceptability
  • Qualitative group interview

aVAS: visual analogue scale.

bCognitive Function Instrument (Norwegian version).

cF-A-S word association test.